Stock & Company Details
AN2 Therapeutics Inc $ANTX
Price:
N/A
N/A
38M
$185M
52 Week High:
N/A
10 Day Average Volume:
N/A
-4.44
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Services
ANTX technical indicators
Latest AN2 Therapeutics Inc (ANTX) indicator readings as of 2026-09-18.
ANTX's 14-day RSI is 38.3, in neutral territory. At $5.05 it is trading 41.2% above its 200-day moving average of $3.58, and below its 50-day average of $5.44. Price sits near the lower Bollinger Band ($5.03 to $6.14). ADX reads 24.2, sitting between trending and range-bound.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.
Finance Bot
Ask your questions
Start by typing a question below.
